Skip to content
healthcare.dev

SODIUM POLYSTYRENE SULFONATE

NDC 11534-166, sodium polystyrene sulfonate, powder, for suspension, from SUNRISE PHARMACEUTICAL, INC..

Product NDC
11534-166
Status
Listed
Labeler
SUNRISE PHARMACEUTICAL, INC.
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL, RECTAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204071
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11534-166 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM POLYSTYRENE SULFONATE4.1 meq/g
Package NDCNDC-11Package
11534-166-151153401661515 g in 1 BOTTLE (11534-166-15)
11534-166-161153401661615 g in 1 BOTTLE (11534-166-16)
11534-166-4411534016644454 g in 1 JAR (11534-166-44)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c73b9661-2378-4336-8be0-098e7c1ae522
  • NADAC price for package 11534016616

    GET /v1/drugs/nadac/11534016616
  • NADAC price for package 11534016644

    GET /v1/drugs/nadac/11534016644

Use it

Look up 11534-166 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11534-166 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11534-166. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.